+499.5%
MRNA vs ZYBT
-83.2%
+582.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ZYBT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.2% | -1.0% | -2.2% |
| 7D | +5.5% | -6.9% | +12.4% | +5.5% |
| 30D | +158.7% | -31.8% | +190.5% | +158.3% |
| 3M | +182.1% | +94.0% | +88.2% | +193.7% |
| 6M | +151.8% | +99.0% | +52.8% | +161.3% |
| YTD | +393.6% | +40.0% | +353.6% | +416.3% |
| 1Y | +499.5% | -79.5% | +579.0% | +567.6% |
| All | +499.5% | -83.2% | +582.7% | +567.6% |
Cumulative growth
Daily Returns
Daily percentage return beside ZYBT.
Daily Out/Under-Performance
Portfolio return minus ZYBT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ZYBT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ZYBT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling